deltatrials
Suspended NA INTERVENTIONAL 1-arm NCT04704648

Feasibility Study of Ocular Surface Squamous Neoplasia Surgical Excision in People Living With HIV in Sub-Saharan Africa

Feasibility Study of Ocular Surface Squamous Neoplasia (OSSN) Surgical Excision in People Living With HIV in Sub-Saharan Africa (SSA)

Sponsor: AIDS Malignancy Consortium

Conditions HPV Ocular Surface Squamous Neoplasia
Interventions Surgical
Updated 14 times since 2021 Last updated: Dec 5, 2025 Started: Jun 21, 2023 Primary completion: Dec 30, 2027 Completion: Dec 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

Retraining on study procedures required

This NA trial investigates HPV and Ocular Surface Squamous Neoplasia and is currently suspended. AIDS Malignancy Consortium leads this study, which shows 14 recorded versions since 2023 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Feb 2021 – ~Sep 2021 · 7 months · monthly snapshot~Sep 2021 – ~Mar 2022 · 6 months · monthly snapshot~Mar 2022 – ~Jul 2022 · 4 months · monthly snapshot~Jul 2022 – ~Dec 2022 · 5 months · monthly snapshot~Dec 2022 – ~Apr 2023 · 4 months · monthly snapshot~Apr 2023 – ~May 2023 · 30 days · monthly snapshot~May 2023 – ~Jun 2023 · 31 days · monthly snapshot~Jun 2023 – ~Jul 2023 · 30 days · monthly snapshot~Jul 2023 – ~Dec 2023 · 5 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshot~Feb 2025 – ~Jan 2026 · 11 months · monthly snapshot~Jan 2026 – present · 5 months · monthly snapshot

Change History

14 versions recorded

  1. Jan 2026 — Present [monthly]

    Suspended NA

  2. Feb 2025 — Jan 2026 [monthly]

    Suspended NA

    Status: Recruiting → Suspended

  3. Sep 2024 — Feb 2025 [monthly]

    Recruiting NA

  4. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  5. Dec 2023 — Jul 2024 [monthly]

    Recruiting NA

▶ Show 9 earlier versions

  1. Jul 2023 — Dec 2023 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  2. Jun 2023 — Jul 2023 [monthly]

    Not Yet Recruiting NA

  3. May 2023 — Jun 2023 [monthly]

    Not Yet Recruiting NA

  4. Apr 2023 — May 2023 [monthly]

    Not Yet Recruiting NA

  5. Dec 2022 — Apr 2023 [monthly]

    Not Yet Recruiting NA

  6. Jul 2022 — Dec 2022 [monthly]

    Not Yet Recruiting NA

  7. Mar 2022 — Jul 2022 [monthly]

    Not Yet Recruiting NA

  8. Sep 2021 — Mar 2022 [monthly]

    Not Yet Recruiting NA

  9. Feb 2021 — Sep 2021 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • AIDS Malignancy Consortium
  • National Cancer Institute (NCI)
Data source: AIDS Malignancy Consortium

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations